Toll Free: +1-855-465-4651 |  sales@marketnreports.com

Find Top Market Research Reports here

Home  >>   Pharmaceuticals & Healthcare  >>   Reports   >>  

Global Human Rabies Immunoglobulin (IM) Market 2018 - Industry Analysis, Production, Share, Growth, Sales, Trends, Supply, Forecast to 2025

 Published Date : Nov-2018   |    Format :PDF   |    Number of Pages : 110
This report studies the global market size of Human Rabies Immunoglobulin (IM) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Rabies Immunoglobulin (IM) in these regions.
This research report categorizes the global Human Rabies Immunoglobulin (IM) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU.
Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%.
China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.
In 2017, the global Human Rabies Immunoglobulin (IM) market size was 290 million US$ and is forecast to 510 million US in 2025, growing at a CAGR of 7.6% from 2018. The objectives of this study are to define, segment, and project the size of the Human Rabies Immunoglobulin (IM) market based on company, product type, application and key regions.

The various contributors involved in the value chain of Human Rabies Immunoglobulin (IM) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Human Rabies Immunoglobulin (IM) include
    CSL Behring
    Grifols
    Sanofi
    Sichuan Yuanda Shuyang
    CNBG
    Kamada
    CBPO
    Shuanglin Bio
    Weiguang Bio
    Shanghai RAAS
    Bharat Serum
    VINS

Market Size Split by Type
    ERIG
    HRIG
Market Size Split by Application
    Category II Exposure
    Category III Exposure

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Human Rabies Immunoglobulin (IM) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Human Rabies Immunoglobulin (IM) market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Human Rabies Immunoglobulin (IM) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Human Rabies Immunoglobulin (IM) with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Human Rabies Immunoglobulin (IM) submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Human Rabies Immunoglobulin (IM) are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Rabies Immunoglobulin (IM) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Human Rabies Immunoglobulin (IM) Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type
        1.4.2 ERIG
        1.4.3 HRIG
    1.5 Market by Application
        1.5.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application
        1.5.2 Category II Exposure
        1.5.3 Category III Exposure
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Human Rabies Immunoglobulin (IM) Market Size
        2.1.1 Global Human Rabies Immunoglobulin (IM) Revenue 2016-2025
        2.1.2 Global Human Rabies Immunoglobulin (IM) Sales 2016-2025
    2.2 Human Rabies Immunoglobulin (IM) Growth Rate by Regions
        2.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Regions
        2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Human Rabies Immunoglobulin (IM) Sales by Manufacturers
        3.1.1 Human Rabies Immunoglobulin (IM) Sales by Manufacturers
        3.1.2 Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers
        3.1.3 Global Human Rabies Immunoglobulin (IM) Market Concentration Ratio (CR5 and HHI)
    3.2 Human Rabies Immunoglobulin (IM) Revenue by Manufacturers
        3.2.1 Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2018)
        3.2.2 Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2016-2018)
    3.3 Human Rabies Immunoglobulin (IM) Price by Manufacturers
    3.4 Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Product Types
        3.4.1 Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Human Rabies Immunoglobulin (IM) Product Category
        3.4.3 Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM)  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Human Rabies Immunoglobulin (IM) Sales by Type
    4.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type
    4.3 Human Rabies Immunoglobulin (IM) Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Human Rabies Immunoglobulin (IM) Breakdown Data by Application

6 North America
    6.1 North America Human Rabies Immunoglobulin (IM) by Countries
        6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Countries
        6.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Human Rabies Immunoglobulin (IM) by Type
    6.3 North America Human Rabies Immunoglobulin (IM) by Application
    6.4 North America Human Rabies Immunoglobulin (IM) by Company

7 Europe
    7.1 Europe Human Rabies Immunoglobulin (IM) by Countries
        7.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Countries
        7.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Human Rabies Immunoglobulin (IM) by Type
    7.3 Europe Human Rabies Immunoglobulin (IM) by Application
    7.4 Europe Human Rabies Immunoglobulin (IM) by Company

8 Asia Pacific
    8.1 Asia Pacific Human Rabies Immunoglobulin (IM) by Countries
        8.1.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Countries
        8.1.2 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Human Rabies Immunoglobulin (IM) by Type
    8.3 Asia Pacific Human Rabies Immunoglobulin (IM) by Application
    8.4 Asia Pacific Human Rabies Immunoglobulin (IM) by Company

9 Central & South America
    9.1 Central & South America Human Rabies Immunoglobulin (IM) by Countries
        9.1.1 Central & South America Human Rabies Immunoglobulin (IM) Sales by Countries
        9.1.2 Central & South America Human Rabies Immunoglobulin (IM) Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Human Rabies Immunoglobulin (IM) by Type
    9.3 Central & South America Human Rabies Immunoglobulin (IM) by Application
    9.4 Central & South America Human Rabies Immunoglobulin (IM) by Company

10 Middle East and Africa
    10.1 Middle East and Africa Human Rabies Immunoglobulin (IM) by Countries
        10.1.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Countries
        10.1.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Human Rabies Immunoglobulin (IM) by Type
    10.3 Middle East and Africa Human Rabies Immunoglobulin (IM) by Application
    10.4 Middle East and Africa Human Rabies Immunoglobulin (IM) by Company

11 Company Profiles
    11.1 CSL Behring
        11.1.1 CSL Behring Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.1.4 Human Rabies Immunoglobulin (IM) Product Description
        11.1.5 Recent Development
    11.2 Grifols
        11.2.1 Grifols Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.2.4 Human Rabies Immunoglobulin (IM) Product Description
        11.2.5 Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.3.4 Human Rabies Immunoglobulin (IM) Product Description
        11.3.5 Recent Development
    11.4 Sichuan Yuanda Shuyang
        11.4.1 Sichuan Yuanda Shuyang Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.4.4 Human Rabies Immunoglobulin (IM) Product Description
        11.4.5 Recent Development
    11.5 CNBG
        11.5.1 CNBG Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.5.4 Human Rabies Immunoglobulin (IM) Product Description
        11.5.5 Recent Development
    11.6 Kamada
        11.6.1 Kamada Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.6.4 Human Rabies Immunoglobulin (IM) Product Description
        11.6.5 Recent Development
    11.7 CBPO
        11.7.1 CBPO Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.7.4 Human Rabies Immunoglobulin (IM) Product Description
        11.7.5 Recent Development
    11.8 Shuanglin Bio
        11.8.1 Shuanglin Bio Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.8.4 Human Rabies Immunoglobulin (IM) Product Description
        11.8.5 Recent Development
    11.9 Weiguang Bio
        11.9.1 Weiguang Bio Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.9.4 Human Rabies Immunoglobulin (IM) Product Description
        11.9.5 Recent Development
    11.10 Shanghai RAAS
        11.10.1 Shanghai RAAS Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Human Rabies Immunoglobulin (IM)
        11.10.4 Human Rabies Immunoglobulin (IM) Product Description
        11.10.5 Recent Development
    11.11 Bharat Serum
    11.12 VINS

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Human Rabies Immunoglobulin (IM) Raw Material
        13.1.2 Human Rabies Immunoglobulin (IM) Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Human Rabies Immunoglobulin (IM)
    Figure Global Human Rabies Immunoglobulin (IM) Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Human Rabies Immunoglobulin (IM) Production Market Share by Types (Product Category) in 2017
    Figure ERIG Product Picture
    Table Major Manufacturers of ERIG
    Figure HRIG Product Picture
    Table Major Manufacturers of HRIG
    Table Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Category II Exposure
    Figure Category III Exposure
    Figure Human Rabies Immunoglobulin (IM) Report Years Considered
    Figure Global Human Rabies Immunoglobulin (IM) Market Size 2016-2025 (Million US$)
    Figure Global Human Rabies Immunoglobulin (IM) Sales 2016-2025 (K Units)
    Table Global Human Rabies Immunoglobulin (IM) Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Human Rabies Immunoglobulin (IM) Sales by Regions 2016-2025 (K Units)
    Table Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions 2016-2025
    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions 2016-2025
    Figure 2017 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Regions
    Table Global Human Rabies Immunoglobulin (IM) Revenue by Regions 2016-2025 (Million US$)
    Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions 2016-2025
    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Regions
    Table Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2018) (K Units)
    Table Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers (2016-2018)
    Figure Global Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers in 2017
    Table Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2018) (Million US$)
    Table Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2016-2018)
    Figure Human Rabies Immunoglobulin (IM) Value Share by Manufacturers in 2017
    Table Global Human Rabies Immunoglobulin (IM) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Human Rabies Immunoglobulin (IM) Price (2016-2018) (USD/Unit)
    Table Human Rabies Immunoglobulin (IM) Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Human Rabies Immunoglobulin (IM) Product Category
    Table Date of International Manufacturers Enter into Human Rabies Immunoglobulin (IM) Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2016-2025)
    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2017
    Table Global Human Rabies Immunoglobulin (IM) Revenue by Type (2016-2025) (Million US$)
    Table Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2016-2025)
    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2016-2025)
    Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type in 2017
    Table Human Rabies Immunoglobulin (IM) Price by Type 2013-2018 (USD/Unit)
    Table Global Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2016-2025)
    Figure Global Sales Human Rabies Immunoglobulin (IM) Market Share by Application (2016-2025)
    Figure Global Sales Human Rabies Immunoglobulin (IM) Market Share by Application (2016-2025)
    Figure North America Human Rabies Immunoglobulin (IM) Sales Growth Rate 2016-2025 (K Units)
    Figure North America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Human Rabies Immunoglobulin (IM) Sales by Countries (2016-2025) (K Units)
    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries
    Table North America Human Rabies Immunoglobulin (IM) Revenue by Countries (2016-2025) (Million US$)
    Table North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries
    Figure United States Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure United States Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure 2017 North America Human Rabies Immunoglobulin (IM) Market Share by Type
    Table North America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2025)
    Figure 2017 North America Human Rabies Immunoglobulin (IM) Market Share by Application
    Table North America Human Rabies Immunoglobulin (IM) Sales by Company (2016-2018) (K Units)
    Table North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2018)
    Figure North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2017
    Figure Europe Human Rabies Immunoglobulin (IM) Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Human Rabies Immunoglobulin (IM) Sales by Countries (2016-2025) (K Units)
    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Countries
    Table Europe Human Rabies Immunoglobulin (IM) Revenue by Countries (2016-2025) (Million US$)
    Table Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries
    Figure Germany Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (K Units)
    Figure France Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure UK Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Human Rabies Immunoglobulin (IM) Market Share by Type
    Table Europe Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Human Rabies Immunoglobulin (IM) Market Share by Application
    Table Europe Human Rabies Immunoglobulin (IM) Sales by Company (2016-2018) (K Units)
    Table Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2018)
    Figure Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2017
    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Countries
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries
    Figure China Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Human Rabies Immunoglobulin (IM) Market Share by Type
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Human Rabies Immunoglobulin (IM) Market Share by Application
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2017
    Figure Central & South America Human Rabies Immunoglobulin (IM) Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Countries (2016-2025) (K Units)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Countries
    Table Central & South America Human Rabies Immunoglobulin (IM) Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries
    Figure Brazil Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Human Rabies Immunoglobulin (IM) Market Share by Type
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Human Rabies Immunoglobulin (IM) Market Share by Application
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales by Company (2016-2018) (K Units)
    Table Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2018)
    Figure Central & South America Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2017
    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Countries
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Countries
    Figure GCC Countries Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Human Rabies Immunoglobulin (IM) Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Share by Type
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Share by Application
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Company in 2017
    Table CSL Behring Company Details
    Table CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table CSL Behring Recent Development
    Table Grifols Company Details
    Table Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Grifols Recent Development
    Table Sanofi Company Details
    Table Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Sichuan Yuanda Shuyang Company Details
    Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sichuan Yuanda Shuyang Recent Development
    Table CNBG Company Details
    Table CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table CNBG Recent Development
    Table Kamada Company Details
    Table Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Kamada Recent Development
    Table CBPO Company Details
    Table CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table CBPO Recent Development
    Table Shuanglin Bio Company Details
    Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shuanglin Bio Recent Development
    Table Weiguang Bio Company Details
    Table Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Weiguang Bio Recent Development
    Table Shanghai RAAS Company Details
    Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shanghai RAAS Recent Development
    Table Bharat Serum Company Details
    Table VINS Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Human Rabies Immunoglobulin (IM) Value Chain
    Table Typical Suppliers of Key Human Rabies Immunoglobulin (IM) Raw Material
    Table Human Rabies Immunoglobulin (IM) Customers List
    Table Human Rabies Immunoglobulin (IM) Sales Channels
    Table Human Rabies Immunoglobulin (IM) Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Latest News
Read more